Venrock

Description

VENROCK PIMPLE PATCH is a specialized acne treatment product designed to address blemishes effectively. Each package contains 48 hydrocolloid patches, each weighing 0.4 grams (0.0141 ounces). The patches are formulated with active ingredients including salicylic acid, tea tree oil, and Centella asiatica oil, which work synergistically to absorb acne secretions and promote rapid healing.

The patches are available in 24 distinct shapes, allowing for targeted application on various types of blemishes. A unique small pet pattern is incorporated to protect the skin from potential sun sensitivity associated with salicylic acid. The formulation is designed to clear acne without leaving scars, ensuring a more aesthetically pleasing outcome.

Uses and Indications

This drug is indicated for the treatment of acne. It aids in the clearance of pimples and blackheads and helps prevent the formation of new acne lesions.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleansed prior to the application of the medication. The medication should be applied to the entire affected area using a patch, which may be administered one to two times daily based on the patient's needs and physician's recommendations.

It is advisable to initiate treatment with one application per day to minimize the risk of excessive skin drying. If tolerated, the frequency may be gradually increased to two applications per day. In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day.

The patch should be removed after a duration of 6 to 8 hours to ensure optimal efficacy and minimize potential skin irritation.

Contraindications

The use of this product is contraindicated in conjunction with other irritating products, including those containing retinoic acid, fruit acid, and similar ingredients, due to the potential for excessive skin irritation.

Warnings and Precautions

For external use only. It is imperative to avoid concurrent use with other irritating products, including those containing retinoic acid, fruit acids, and similar ingredients, as this may lead to excessive skin irritation.

Contact with sensitive areas such as the eyes, lips, and mouth should be strictly avoided. In the event of accidental contact, it is essential to rinse the affected area thoroughly with water. The likelihood of skin irritation and dryness increases when used in conjunction with other topical acne medications; therefore, it is recommended to use only one topical acne treatment at a time to minimize the risk of irritation.

Users may experience mild irritation, which can manifest as redness, burning, itching, peeling, or dryness. To mitigate these effects, unnecessary sun exposure should be avoided. Should skin irritation become severe or worsen, it is advised to discontinue use and consult a healthcare professional. Additionally, if a rash or allergic reaction develops, or if the condition does not show improvement after 7 days of use, medical advice should be sought.

For individuals who are pregnant or breastfeeding, consultation with a healthcare professional prior to use is recommended. In the case of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Patients with sensitive skin or those suffering from severe acne should consult a doctor or pharmacist before initiating use to ensure safety and appropriateness of the treatment.

Side Effects

Patients using this product should be aware that it is intended for external use only. Caution is advised to avoid the use of other irritating products, such as those containing retinoic acid or fruit acids, as this may lead to excessive skin irritation. Contact with the eyes, lips, and mouth should be avoided; in the event of contact, the affected area should be rinsed thoroughly with water.

Common adverse reactions may include mild irritation characterized by redness, burning, itching, peeling, or dryness of the skin. The likelihood of skin irritation and dryness increases when this product is used concurrently with other topical acne medications. Therefore, it is recommended that only one topical acne medication be used at a time to minimize the risk of irritation. Patients are also advised to avoid unnecessary sun exposure while using this product.

Patients should discontinue use and consult a healthcare professional if skin irritation becomes severe or worsens, if a rash or allergic reaction develops, or if their condition does not improve after 7 days of use. Individuals with sensitive skin or severe acne should seek advice from a doctor or pharmacist prior to use.

In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

Concurrent use of irritating products, including those containing retinoic acid or fruit acids, should be avoided to prevent excessive skin irritation. The combination of these agents may exacerbate skin irritation and dryness.

Additionally, the simultaneous application of multiple topical acne medications increases the likelihood of skin irritation and dryness. To minimize the risk of adverse effects, it is recommended that only one topical acne medication be used at a time. Monitoring for signs of irritation is advised, and if such symptoms occur, discontinuation of one of the products should be considered.

Packaging & NDC

Below are the non-prescription pack sizes of Venrock (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this medication. It is important to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or a Poison Control Center should be contacted.

For topical application, it is recommended to start with one application daily to minimize the risk of excessive skin drying. If necessary, the frequency may be gradually increased to two times daily, based on the patient's needs or as directed by a healthcare professional. Should bothersome dryness or peeling occur, the application frequency should be reduced to once a day or every other day.

Geriatric Use

There is no specific information regarding the use of VENROCK - salicylic acid patch in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for any adverse effects is advisable, given the lack of established guidelines for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of accidental ingestion, it is imperative to seek immediate medical assistance or contact a Poison Control Center. Prompt action is crucial to mitigate potential risks associated with overdosage.

Healthcare professionals should be aware that symptoms of overdosage may vary depending on the substance involved. Monitoring for any adverse effects is essential, and appropriate management should be initiated based on the clinical presentation.

Management procedures may include supportive care and symptomatic treatment as necessary. Continuous assessment of the patient's condition is recommended to ensure timely intervention and to address any complications that may arise from the overdosage.

Nonclinical Toxicology

If pregnant or breast-feeding, it is advised to consult a health professional prior to use.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of accidental ingestion of the product. It is important to instruct patients to discontinue use and consult a doctor if they experience severe or worsening skin irritation. Additionally, patients should be informed to stop using the product and seek medical advice if they develop a rash or any signs of an allergic reaction.

Patients should also be counseled to stop using the product and consult a healthcare professional if their condition does not show improvement after seven days of use. When using this product, it is crucial to avoid combining it with other irritating products, such as those containing retinoic acid or fruit acids, to prevent excessive skin irritation.

Furthermore, healthcare providers should recommend that patients consult with a doctor or pharmacist prior to use if they have sensitive skin or if they are dealing with severe acne. This precaution will help ensure the safe and effective use of the product.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It should be stored at room temperature, within the range of 15° to 30°C (59° to 86°F). Care must be taken to protect the product from excessive heat and direct sunlight to ensure its integrity and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Venrock, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)